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Heart failure is a progressive and disabling disease. The incidence of heart failure is also on the rise, particularly in the elderly of
industrialized societies. This is in part due to an increased ageing population, whom initially beneﬁts from improved, and life-
extending cardiovascular therapy, yet ultimately succumb to myocardial failure. A major cause of heart failure is ischemia secon-
dary to the sequence of events that is dyslipidemia, atherosclerosis, and myocardial infarction. In the case of heart failure postmyo-
cardial infarction, ischemia can lead to myocardial cell death by both necrosis and apoptosis. The extent of myocyte death post-
infarction is associated with adverse cardiac remodeling that can contribute to progressive heart chamber dilation, ventricular
wall thinning, and the onset of loss of cardiac function. In cardiomyocytes, recent studies indicate that myocardial ischemic injury
activatestheunfoldedproteinstressresponse(UPR)andthisisassociatedwithincreasedapoptosis.Thispaperfocusesontheinter-
section of ischemia, the UPR, and cell death in cardiomyocytes. Targeting of the myocardial UPR may prove to be a viable target
for the prevention of myocyte cell loss and the progression of heart failure due to ischemic injury.
1.Introduction
Heart failure (HF) is a common condition and leading cause
of hospitalization in the United States and developed coun-
tries. HF can be debilitating and lead to reduced cardiac
output,physicaldisability,andmortality.ThenumbersofHF
cases in the USA are increasing, in line with a rise in the
elderly population who are at increased risk [1, 2]. Common
causes of HF include ischemic heart disease (including myo-
cardial infarction), hypertension, cardiomyopathy, and val-
vular heart disease. In the case of ischemic heart disease and
myocardial infarction (MI), advances in patient care have
reduced the risk of susceptibility to MI and of immediate
death. Thus, while there has been an increase in the numbers
who initially survive an acute MI, this improvement has
been oﬀset by more survivors progressing to HF [3]. This
deterioration often leads to left ventricular systolic dysfunc-
tion and can be linked to the initial cardiac damage and
remodelingearlyaftermyocardialischemia.Thus,newthera-
peutic targets and treatments are needed to combat the mor-
bidity and mortality caused after MI-induced HF.
1.1. Cardiomyocyte Death in HF. To date, the failure of a
heart to deliver blood that is suﬃcient for the metabolic
needs of the body is largely irreversible. Loss of cardiomy-
ocytes by cell death contributes to reduced cardiac output. In
the case of myocardial infarction, acute ischemia can lead to
signiﬁcant levels of cardiomyocyte death. Myocardial ische-
mia after MI is a signiﬁcant cellular stress that promotes
cardiomyocyte death by either necrosis or apoptosis [4]. In
patients, increased myocardial apoptosis has been associated
with unfavorable ventricular remodeling and early symp-
tomsofpostMIheartfailure[5].Adversecardiacremodeling
involves scar and ﬁbrous tissue formation, whereby the
chambers of the heart enlarge and contractility become less
eﬃcient [6]. At the cellular level, death of the cardiomyocyte
depends on the duration of ischemia and also on the capa-
city of the myocyte to respond to the ischemic stress. Nume-
rous cellular responses have been identiﬁed in cardiomy-
ocytesunderischemicstressandHF.Forexample,autophagy
is activated in HF and may suppress hypertrophy through
increased protein degradation [7]. Accumulating evidence2 Biochemistry Research International
indicates that another signiﬁcant stress response in car-
diomyocytes can aﬀect cell survival. During ischemia, the
unfolded protein response (UPR) or integrated stress res-
ponse is activated in myocytes, as described below.
1.2. The UPR. In noncardiac cells, the UPR signals from the
endoplasmic reticulum [8], which is responsible for the syn-
thesis and folding of proteins, as well as calcium storage and
other signaling pathways. Under conditions that perturb
endoplasmic reticulum homeostasis, the ER has the capacity
to adapt and activate the UPR to compensate and attempt
to restore organelle equilibrium [8]. The function of the
UPR is to protect the ER from normal and pathophysiolo-
gical perturbations in development and disease that include
elevated protein synthesis, disruption of ER calcium home-
ostasis, changes in redox potential, and disturbances in the
physical properties of the ER membrane bilayer [9, 10]. The
UPR is composed of three main signaling branches. These
include inositol-requiring enzyme-1 (IRE-1) [11] activating
transcription factor-6 (ATF6) [12] and PKR-like eukaryotic
initiation factor 2 kinase (PERK) [13]. Activation of the UPR
regulates multiple compensatory gene expression pathways,
including induction of protein-folding chaperones, phos-
pholipid biosynthesis, oxidoreductases, and the promotion
of terminally misfolded protein degradation, through the
ER-associated degradation pathway (ERAD) [8, 14, 15]. The
UPR also exerts translational control by phosphorylating
the eukaryotic initiating factor eIF2α and selectively reduces
protein translation to lessen the load on the ER [16]. These
compensatorypathwaysactﬁrstinanattempttoreconstitute
cell and ER homeostasis. If homeostasis is restored, this
induces a negative feedback of the UPR [17]. If disequilib-
rium persists, proapoptotic pathways can be induced [18], as
discussed below.
1.3. SR/ER and the UPR. Within the cardiomyocyte, the sar-
coplasmic reticulum (SR) is a specialized endoplasmic retic-
ulum and extensive network within the cell that regulates
calcium (Ca2+) ﬂux and excitation contraction coupling.
Under conditions of heart disease, the SR is expanded, con-
sistent with a compensatory response to stress [19]. Through
the years, the terms sarcoplasmic reticulum and endoplas-
mic reticulum have been used interchangeably. Indeed,
numerous canonical ER proteins, including protein chap-
erones, can be found in myocytes after relatively crude
biochemical fractionations of the SR. Such ER proteins that
have been identiﬁed in cardiac tissue include Bip, Grp94,
calnexin, PDI, and others [20–22]. Cardiomyocytes, like
other cells, require these proteins and chaperones to pro-
mote protein folding and other housekeeping functions
synonymous with the ER. In addition to encoding canon-
ical ER-resident proteins, cardiomyocytes can also activate
the UPR in response to characteristic UPR inducers, such
as protein-folding disequilibrium. For example, the Lys-
Asp-Glu-Leu (KDEL) receptor, an ER retrieval receptor for
protein chaperones, promotes chaperone accumulation in
the ER/early secretory pathway. In an experimental mo-
del of forced gene activation, transgenic expression of a
dysfunctional KDEL receptor induced UPR markers in
myocardial tissue [23]. Such protein-folding disorders in the
heart have also been linked to cardiomyocyte death, as trans-
genic overexpression of preamyloid oligomers induces apop-
tosis in cardiomyocytes [24]. In another example of myocar-
dial protein dysregulation, a R120G mutation in CryAB
(crystallin, alpha B), a small heat shock protein, is linked
to familial cardiomyopathy. This mutation induces CryAB
protein aggregation and in mice, overexpression of R120G
mutantCryABinducescardiomyopathy,whereasoverexpres-
sionofitswild-typecounterpartdoesnot[25].Furthermore,
conditions of increased protein synthesis, such as during
hypertrophy, appear to activate the UPR [26]. Some have
interestingly suggested that the SR and ER are spatially and
functionally distinct [27, 28]. Regardless of this distinction,
cardiomyocyte stress induces the UPR, and conditions that
can adversely aﬀect protein folding, similar to in noncar-
diomyocytes, are toxic in the myocardium and linked to
activation of UPR pathways.
1.4. Ischemic Stress. In experimental models of myocardial
ischemia, activation of UPR chaperones has been shown to
occur during development of ischemic heart disease [29].
Ischemia is a major contributor to heart failure, and the
reduction in supply of oxygen to the heart is a signiﬁcant
stress on myocardial tissue. Even prior to myocardial infarc-
tion, expanding atherosclerotic plaque in coronary arteries
r e d u c e sb l o o dﬂ o wa n do x y g e ni nd o w n s t r e a mc o r o n a r y
tissue. Loss of perfusion leads to a drop in oxygen and a tran-
sitiontoglycolyticenergyproduction.Ischemicmyocardium
is characterized by reduced oxidative phosphorylation and
increased anaerobic metabolism [30]. Reliance on glycolysis
andaccumulationofinorganicphosphatealsoleadtocellular
acidiﬁcationthroughincreasesinlacticacidproduction[31].
These factors in combination can signiﬁcantly compromise
cellular energy production by reducing generation of adeno-
sine triphosphate (ATP). Ischemia also contributes to mito-
chondria dysfunction. In heart cells, mitochondria swell and
release cytochrome C, contributing to contractile dysfunc-
tion [32]. When prolonged, ischemia will promote caspase-
mediated apoptosis in cardiomyocytes. In vitro, ischemia
can be simulated through deprivation of serum, glucose, and
oxygen (SGO). Ischemia, in other tissues, has been shown
to lead to the impairment of protein folding in the ER,
leading to activation of the UPR. Hypoxia alone leads to dys-
functional disulﬁde bond generation by oxygen-dependent
protein disulﬁde isomerase and this in turn leads to protein
misfolding and activation of the UPR [33]. Reoxygenation
eﬀects on the UPR in cardiomyocytes also are a signiﬁcant
factor [34]. Below, we highlight how ischemia can lead to
modulation of the UPR in the heart. Ischemia has been
linked to the activation of all three arms of the UPR as des-
cribed next.
2. The CardiomyocyteUPR
2.1. The Cardiomyocyte IRE-1α Pathway and Ischemia. The
ER transmembrane protein IRE-1α is homodimerized dur-
ing ER stress to induce autophosphorylation. Homodimer-
















Figure 1: Working model of the cardiomyocyte unfolded protein response during ischemia. Activators of the UPR in cardiomyocytes at
the sarcoplasmic reticulum (SR)/endoplasmic reticulu (ER) include ischemia during cardiovascular disease. Proximal eﬀectors of the UPR
include IRE-1α, ATF6, and PERK. IRE-1α induces splicing of Xbp-1 mRNA and can promote prosurvival or proapoptotic pathways. ATF6
proteolysis leads to transcription of ER stress responsive genes and has been implicated in cardiomyocyte cell survival. Initial eﬀects of PERK
includetranslationalarrestthatreducestheloadontheSR/ERfoldingmachinery.DownstreamanddistaleﬀectorresponsesofPERKinclude
CHOP, which promotes cardiomyocyte apoptosis and may contribute to heart failure.
an accumulation of misfolded protein in the ER [35]. ER
stress also activates an IRE-1α endoribonuclease activity that
splices X-box-binding protein-1 (Xbp-1)m R N A( Figure 1).
Spliced Xbp-1 (sXbp-1) encodes a basic leucine-zipper and
activeformofXBP-1,whichinducesERstressresponsegenes
[36, 37] that escape PERK-mediated translational arrest
(discussed below). The requirement for the UPR in the
heart and the IRE-1α pathway begins during embryonic
development. GRP78 (guanine-nucleotide-releasing protein
78), an IRE-1α and ATF6 downstream target, is upregulated
in the embryonic mouse myocardium. In addition, Xbp-1
is required for heart formation as Xbp-1 deﬁcient mice
die in utero. Xbp-1 knockout mice death occurs in asso-
ciation with signiﬁcant cardiomyocyte death [38]. Consis-
tent with a prosurvival role for XBP-1, inhibition of IRE-1α
reduces chemokine-induced autophagic cell death in H9c2
cardiomyocytes [39]. In experimental models of ischemia (in
hearts post MI), the IRE-1α downstream target GRP78 is
upregulatedinmyocardialtissueproximaltotheinfarct[40].
Ex vivo (in a Langendorﬀ heart perfusion system), GRP78,
and sXbp-1 are induced during simulated ischemia and
reperfusion [41]. In vitro, primary neonatal rat cardiomy-
ocytes exposed to serum, glucose, and oxygen deprivation
(SGO) can induce spliced Xbp-1 mRNA, and this occurs
within hours [42]. As evidence for a causal role of XBP-1
during ischemia, adenoviral dominant negative XBP-1 exp-
ressionresultedinincreasedhypoxia-reoxygenation-induced
apoptosis. The IRE-1α pathway has also been implicated
in proapoptotic pathways as well. For example, in noncar-
diomyocytes, IRE-1α can interact with the adaptor protein
TNFreceptor-associatedfactor(TRAF2).IRE-1αandTRAF2
subsequently act on ASK1 (mitogen-activated protein kinase
kinasekinase),whichphosphorylatesproapoptoticJNK[43].
Less is known regarding how such a proapoptotic IRE-1α
pathway may function in cardiomyocytes. In addition, cal-
cium dysregulation is an important component of ischemic
heart failure and upregulation of sarco/endoplasmic retic-
ulum calcium-ATPase isoform 3f (SERCA3f) is associated
with heart failure [44]. Experimental overexpression of
SERCA3f has been shown to induce Xbp-1 splicing. Also,
cardiomyocyte-speciﬁc disruption of the calcium regulator
Serca2 induces the UPR and promotes apoptosis [44]. Over-
expression of the downstream target of XBP-1, GRP94 redu-
ced H9c2 cardiomyocyte necrosis induced by both calcium
overload and ischemia [45]. Thus, although the aforemen-
tioned examples indicate a signiﬁcant role for the IRE-1α
pathway in cardiomyocyte survival and during calcium regu-
lation, much remains to be understood, including how the
prosurvival roles of IRE-1α signaling may diﬀerentially act
during development versus after ischemic injury.4 Biochemistry Research International
2.2.ActivatingTranscriptionFactor6(ATF6)intheHeart. On
activation of the UPR, ATF6 travels to the Golgi, where its
cleavage leads to the translocation of its cytosolic fragment
to the nucleus and binding to ER stress response elements
(ERSEs). Cleaved ATF6 then promotes transcription of
ER-targeted genes, such as the ER chaperone, GRP78. In
mice after MI, inhibition of ATF6 activation with 4-(2-
aminoethyl) benzenesulfonyl ﬂuoride, an inhibitor of ATF6,
impaired cardiac function and increased mortality. In con-
trast, cardiac function after MI was improved in mice exp-
ressing a constitutively active mutant of Atf6, compared with
wild-type littermates [46] and consistent with a protective
role. In primary murine cardiac myocytes exposed to oxygen
and nutrient deprivation, membrane-associated ATF6 was
reduced with a concomitant increase in nuclear ATF6 [47].
This ischemia-induced event was accompanied by ATF6
binding to the ERSE of GRP78, transcriptional upregulation
of GRP78 and was reversible by simulated reperfusion in
vitro. More importantly, a dominant-negative form of ATF6
prevented inducement of Grp78 and promoted cardiomy-
ocyte cell death, indicating a prosurvival role for ATF6. ATF6
has also been shown to induce ER-associated degradation
(ERAD). ERAD has been shown to alleviate ER stress by
degrading misfolded protein in the ER [15]. Interestingly,
Belmont et al. discovered that Derlin-3, a component of
ERAD, is induced by ATF6 in the mouse heart [48]. Further-
more, overexpression of Derlin-3 protected cardiomyocytes
in vitro from simulated ischemia-induced apoptosis. In
another article by Belmont, transcriptional proﬁling inden-
tiﬁed modulatory calcineurin interacting protein-1 (MCIP1),
also known as regulator of calcineurin 1 (RCAN1), as a
novel ATF6-inducible gene. They found that ATF6 was able
to induce RCAN1 in cultured cardiac myocytes and that
adenoviral overexpression of activated ATF6 further induced
RCAN1andmodulatedcellgrowth[49].Thus,ATF6isindu-
ced under ischemic conditions and can play a role to help
protect cardiomyocyte survival. Interestingly, an ATF6 iso-
form and other ATF6-related proteins may play a role in
regulating the UPR, however, their full roles in cardiomy-
ocytes remain undetermined and should be subject of future
investigation [50].
2.3. Cardiomyocyte PERK (dsRNA-Activated Protein Kinase-
Like Endoplasmic Reticulum Kinase). Though the IRE-1α
and ATF6 branches have for the most part been associ-
ated with prosurvival roles in cardiomyocytes, prolonged
activation of the PERK/ATF4/CHOP pathway is principally
implicated in cardiomyocyte cell death. Downstream of
PERK, phosphorylation of eIF2α can be detected as early as
one hour after ischemia in vitro in cardiomyocytes [42].
Eukaryotic translation initiation factor 2α (eIF2α) phospho-
rylation leads to a transient downregulation of the majority
of protein synthesis through inhibition of cap-dependent
protein translation. Only transcripts encoded by ER stress
response genes are induced, reducing the demands on the
ER. This may have implications in prevention of cardiac
hypertrophy and is part of the initial compensatory pathway
of the PERK branch towards promoting survival. Under
prolonged ER stress, C/EBP homologous protein (CHOP) is
induced. Myocardial tissue from patients with heart failure
exhibits increased Chop mRNA. Okada et al. reported that
prolongedERstressoccursinhypertrophicandfailinghearts
after aortic constriction [51]. Also, Chop deﬁciency reduces
cardiac apoptosis in a pressure overload model of heart
disease [52]. CHOP has also been implicated in dilated car-
diomyopathy[23].In vitro,inheartcells,prolongedERstress
induced by ischemia promoted the activation of CHOP [42],
processing of procaspase-12 and induction of apoptosis.
Consistent with activation by ischemia, Chop transcription is
also regulated by amino acid starvation. For example, an up-
stream cis amino acid response element in Chop has been
found to bind activating transcription factor 2 (ATF-2) and
expression of ATF-2 is required for the transcriptional acti-
vation of Chop by leucine starvation in vitro [53]. In support
of this pathway being activated during ischemia, ATF-2 is
stabilized by hypoxia [54]. More recently, prostatic androgen
repressed message-1 or PARM was identiﬁed to be predomi-
nantly expressed in cardiomyocytes and a negative regulator
of CHOP-mediated apoptosis [55]. Finally, Chop deﬁciency
has been shown to reduce myocardial reperfusion injury in a
mousemodelofMI[56].Futurestudiesinvivoarewarranted
to separate the eﬀects of CHOP after ischemia as opposed to
after reperfusion.
3. Discussion
Although treatments for heart failure have advanced, the
incidence of HF is still rising and new therapies remain an
important goal. There is now mounting evidence of a sig-
niﬁcant role for the UPR in cardiomyocytes during ischemic
heart disease. Much remains to be understood with respect
to how individual branches of the UPR diﬀerentially or syn-
ergisticallycontributetoprogressionofheartfailureandhow
these pathways diﬀer from requirements of the UPR during
development. In addition, the therapeutic and prophylactic
potential of modulating the heart is far from complete. Some
have suggested that ischemic preconditioning of the heart
and activation of the UPR may promote cardiac cell survival.
Interesting proofs of principle have been published. For
example,invitro,overexpressionofER-stress-inducedGrp94
has been shown to inhibit cardiomyocyte necrosis after cal-
cium overload and simulated ischemia [45]. Overexpression
of GRP78 has also been shown to have an eﬀect. Forced
GRP78 expression inhibited apoptosis in rat ventricular
myocytes [57]. Also, preconditioning of H9c2 neonatal car-
diomyocytes cells with the ER-stressor tunicamycin has been
shown to protect against ATP deletion [58]. These are
laudable starts, but much work remains to be done. Future
questionsremain.Forexample:Whatistheeﬀectofchemical
chaperones on cardiac stress pathways and cardiac function
[59]? Future studies will also be required to dissect the eﬀects
of cell-speciﬁc deletion of UPR genes in the heart, including
cardiomyocytes, myoﬁbroblasts, and inﬂammatory cells that
inﬁltrate into the myocardium after injury. UPR-targeted
therapies may be realized by promoting the cytoprotective
function of the UPR in the myocyte. Such an approach
may induce UPR-speciﬁc ER chaperones and downstreamBiochemistry Research International 5
prosurvival pathways that work to enhance cardiac function
and prevent cardiomyocyte death.
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